# OnCo record zeest-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/zeest-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "zeest-bio" ;
  schema:name "ZEeST Bio"@en ;
  schema:alternateName "ZEEST BIO INC"@en ;
  schema:description "ZEeST Bio is developing radioactive medicines that use the liver's own uptake biology to carry radiation into liver tumours, with the same agent used for scanning. Its lead programme is for hepatocellular carcinoma, the commonest primary liver cancer, and is in laboratory testing."@en ;
  schema:url <https://onco.cc/companies/zeest-bio/>, <https://zeest.bio/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://zeest.bio/>, <https://reporter.nih.gov/project-details/11405078> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/hcc/> ;
  onco:sections <https://onco.cc/fronts/radiopharma/> ;
  onco:drugs <https://onco.cc/drugs/zst-101/> .